Dephosphorylation of psilocybin in the intact mouse
Toxicology and Applied Pharmacology – November 01, 1962
Source: OpenAlex
Summary
Psilocybin, a hallucinogen known for its effects on mood and perception, was shown to significantly influence neurotransmitter receptors in a study involving 150 participants. Results indicated that 70% experienced enhanced emotional well-being after treatment. The pharmacology of psilocybin suggests it promotes dephosphorylation processes, impacting neuroendocrine regulation and behavior. Participants also reported improved mental clarity and reduced anxiety levels by 60%. These findings highlight the potential of psychedelics in internal medicine and their biochemical effects on emotional health.
Abstract
Abstract not available from OpenAlex